{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:47:48Z","timestamp":1782143268032,"version":"3.54.5"},"reference-count":35,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"unspecified","delay-in-days":172,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"BHF","award":["PG\/21\/10631"],"award-info":[{"award-number":["PG\/21\/10631"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2026,5,30]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>This study investigated the influence of depression status on lipid lowering therapy (LLT) prescribing and achievement of guideline targets for low density lipoprotein cholesterol (LDL-C) levels in patients after first documentation of a high risk of developing atherosclerotic cardiovascular disease (ASCVD). Associations with sex, socioeconomic status and location of residence on these relationships were also explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective observational cohort study (2010\u20132019) using individual-level linked, anonymised, routinely collected electronic health record data sources. Patients with\/without depression and documentation of a high global QRISK risk score (HQR) were included. Outcome variables were LLT prescription within 6 months of HQR documentation and recording of LDL-C level within European Society of Cardiology\/European Atherosclerosis Society (ESC\/EAS) targets and achievement of &gt;40% reduction in LDL-C according to National Institute for Health and Care Excellence guidance within 1 year of HQR. Logistic regression analysis explored the association between depression and outcome variables adjusting for sex, age group, deprivation, location of residence and other risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>QRISK was documented in 284\u2009859 (12.8%) patients. In the 103 340 HQR patients, depression (identified pre-HQR or post-HQR documentation) was associated with a higher likelihood of LLT prescription (pre-OR 1.15, 95%\u2009CI 1.08 to 1.23; post-OR 1.39, 95%\u2009CI 1.19 to 1.64). Depression was not associated with achievement of LDL-C control as per EAS\/ESC guidelines (&lt;2.6\u2009mmol\/L; pre-OR 1.10, 95%\u2009CI 1.00 to 1.23; post-OR 1.00, 95%\u2009CI 0.79 to 1.28). Depression pre-HQR was associated with achievement of a &gt;40% reduction in LDL-C (pre-OR 1.16, 95% CI 1.02 to 1.32; post-OR 0.94, 95%\u2009CI 0.70 to 1.25)<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Only a small proportion of patients had a documented QRISK score in their record. While high ASCVD risk patients with depression were more likely to be prescribed LLT, this was not necessarily associated with better LDL-C control.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/openhrt-2025-003800","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T14:56:10Z","timestamp":1782140170000},"page":"e003800","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment and control of low-density lipoprotein for primary prevention in patients in Wales with and without depression: a study of whole-population electronic health records"],"prefix":"10.1136","volume":"13","author":[{"given":"Carla","family":"White","sequence":"first","affiliation":[{"name":"Swansea University Medical School, Swansea University, Swansea, Wales, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Summers","sequence":"additional","affiliation":[{"name":"Swansea University Medical School, Swansea University, Swansea, Wales, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"John","sequence":"additional","affiliation":[{"name":"Swansea University Medical School, Swansea University, Swansea, Wales, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David PJ","family":"Osborn","sequence":"additional","affiliation":[{"name":"Division of Psychiatry, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Lloyd","sequence":"additional","affiliation":[{"name":"Swansea University Medical School, Swansea University, Swansea, Wales, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Akbari","sequence":"additional","affiliation":[{"name":"Swansea University Medical School, Swansea University, Swansea, Wales, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B","family":"Gravenor","sequence":"additional","affiliation":[{"name":"Swansea University Medical School, Swansea University, Swansea, Wales, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian P","family":"Halcox","sequence":"additional","affiliation":[{"name":"Swansea University Medical School, Swansea University, Swansea, Wales, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5164-6416","authenticated-orcid":false,"given":"Elizabeth A","family":"Ellins","sequence":"additional","affiliation":[{"name":"Swansea University Medical School, Swansea University, Swansea, Wales, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"2026062207552179000_13.1.e003800.1","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170\u2008000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"The Lancet"},{"key":"2026062207552179000_13.1.e003800.2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl338"},{"key":"2026062207552179000_13.1.e003800.3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264529","article-title":"Achievement of European Society of Cardiology\/European Atherosclerosis Society lipid targets in very high-risk patients: Influence of depression and sex","volume":"17","author":"Ellins","year":"2022","journal-title":"PLoS One"},{"key":"2026062207552179000_13.1.e003800.4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/PPA.S182765","article-title":"Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk","volume":"13","author":"Katzmann","year":"2019","journal-title":"Patient Prefer Adherence"},{"key":"2026062207552179000_13.1.e003800.5","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2009.36"},{"key":"2026062207552179000_13.1.e003800.6","doi-asserted-by":"crossref","DOI":"10.5334\/gh.1284","article-title":"Sex Differences in the Primary Prevention of Cardiovascular Diseases in a Dutch Primary Care Setting","volume":"19","author":"Kiss","year":"2024","journal-title":"Glob Heart"},{"key":"2026062207552179000_13.1.e003800.7","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2020-317446"},{"key":"2026062207552179000_13.1.e003800.8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104671","article-title":"Socioeconomic deprivation and the incidence of 12 cardiovascular diseases in 1.9 million women and men: implications for risk prediction and prevention","volume":"9","author":"Pujades-Rodriguez","year":"2014","journal-title":"PLoS One"},{"key":"2026062207552179000_13.1.e003800.9","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.186.5.417"},{"key":"2026062207552179000_13.1.e003800.10","doi-asserted-by":"publisher","DOI":"10.1136\/jech.2008.082719"},{"key":"2026062207552179000_13.1.e003800.11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172618","article-title":"Equity in healthcare for coronary heart disease, Wales (UK) 2004-2010: A population-based electronic cohort study","volume":"12","author":"King","year":"2017","journal-title":"PLoS One"},{"key":"2026062207552179000_13.1.e003800.12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/pubmed\/fdl068","article-title":"Social deprivation and statin prescribing: a cross-sectional analysis using data from the new UK general practitioner \u2018Quality and Outcomes Framework\u2019","volume":"29","author":"Ashworth","year":"2007","journal-title":"J Public Health (Bangkok)"},{"key":"2026062207552179000_13.1.e003800.13","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6963-14-414","article-title":"Variations in statin prescribing for primary cardiovascular disease prevention: cross-sectional analysis","volume":"14","author":"Fleetcroft","year":"2014","journal-title":"BMC Health Serv Res"},{"key":"2026062207552179000_13.1.e003800.14","doi-asserted-by":"crossref","unstructured":"Asthana S , Gibson A , Bailey T , et al . Health Services and Delivery Research. In: Equity of Utilisation of Cardiovascular Care and Mental Health Services in England: A Cohort-Based Cross-Sectional Study Using Small-Area Estimation. Southampton (UK): NIHR Journals Library, 2016.","DOI":"10.3310\/hsdr04140"},{"key":"2026062207552179000_13.1.e003800.15","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6947-9-3","article-title":"The SAIL databank: linking multiple health and social care datasets","volume":"9","author":"Lyons","year":"2009","journal-title":"BMC Med Inform Decis Mak"},{"key":"2026062207552179000_13.1.e003800.16","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6963-9-157","article-title":"The SAIL Databank: building a national architecture for e-health research and evaluation","volume":"9","author":"Ford","year":"2009","journal-title":"BMC Health Serv Res"},{"key":"2026062207552179000_13.1.e003800.17","doi-asserted-by":"crossref","unstructured":"Ellins EA , Summers R , John A , et al . Cardiovascular Risk Assessment in Male and Female Patients With and Without Depression: an Electronic Health Record Evaluation in Wales. Eur J Prev Cardiol 2025.:zwaf178. doi:10.1093\/eurjpc\/zwaf178","DOI":"10.1093\/eurjpc\/zwaf178"},{"key":"2026062207552179000_13.1.e003800.18","unstructured":"National Institue for Health and Care Excellence . Cardiovascular disease: risk assessment and reduction, including lipid modification NG238. 2023."},{"key":"2026062207552179000_13.1.e003800.19","doi-asserted-by":"crossref","DOI":"10.1186\/s12911-016-0274-7","article-title":"Case-finding for common mental disorders of anxiety and depression in primary care: an external validation of routinely collected data","volume":"16","author":"John","year":"2016","journal-title":"BMC Med Inform Decis Mak"},{"key":"2026062207552179000_13.1.e003800.20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0326583","article-title":"Treatment and control of blood pressure in Welsh patients with and without depression: A study of whole-population electronic health records","volume":"20","author":"Ellins","year":"2025","journal-title":"PLoS One"},{"key":"2026062207552179000_13.1.e003800.21","doi-asserted-by":"crossref","unstructured":"White C , Summers R , John A , et al . Treatment and control of low-density lipoprotein cholesterol in patients in Wales: impact of depression. Eur J Prev Cardiol 2025.:zwaf658. doi:10.1093\/eurjpc\/zwaf658","DOI":"10.1093\/eurjpc\/zwaf658"},{"key":"2026062207552179000_13.1.e003800.22","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/18.6.499"},{"key":"2026062207552179000_13.1.e003800.23","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw272"},{"key":"2026062207552179000_13.1.e003800.24","doi-asserted-by":"crossref","DOI":"10.1017\/S2045796020001006","article-title":"NHS Health Checks for people with mental ill-health 2013-2017: an observational study","volume":"29","author":"Garriga","year":"2020","journal-title":"Epidemiol Psychiatr Sci"},{"key":"2026062207552179000_13.1.e003800.25","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2011.256"},{"key":"2026062207552179000_13.1.e003800.26","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.14.2101"},{"key":"2026062207552179000_13.1.e003800.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2004.08.035"},{"key":"2026062207552179000_13.1.e003800.28","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwae233"},{"key":"2026062207552179000_13.1.e003800.29","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2023.100624","article-title":"Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study","volume":"29","author":"Ray","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"2026062207552179000_13.1.e003800.30","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.atherosclerosis.2017.08.013","article-title":"Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II","volume":"266","author":"Gitt","year":"2017","journal-title":"Atherosclerosis"},{"key":"2026062207552179000_13.1.e003800.31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1801495"},{"key":"2026062207552179000_13.1.e003800.32","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-072098","article-title":"Estimated impact from the withdrawal of primary care financial incentives on selected indicators of quality of care in Scotland: controlled interrupted time series analysis","volume":"380","author":"Morales","year":"2023","journal-title":"BMJ"},{"key":"2026062207552179000_13.1.e003800.33","unstructured":"National Institute for Health and Care Excellence . Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia. Technology appraisal guidance (TA393). 2016."},{"key":"2026062207552179000_13.1.e003800.34","unstructured":"National Institute for Health and Care Excellence . Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia. Technology appraisal guidance (TA394).. 2016."},{"key":"2026062207552179000_13.1.e003800.35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186861","article-title":"Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? \u2012 Data from a multicenter registry cohort study in Taiwan","volume":"12","author":"Yeh","year":"2017","journal-title":"PLoS ONE"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2025-003800","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T14:56:22Z","timestamp":1782140182000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2025-003800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,6,22]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/openhrt-2025-003800"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2025-003800","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}